Effectiveness of BNT162b2 (Comirnaty, Pfizer-BioNTech) COVID-19 booster vaccine against covid-19 related symptoms in England: test negative case-control study

Nick Andrews, Julia Stowe, Freja Kirsebom, Charlotte Gower, Mary Ramsay, Jamie Lopez Bernal
doi: https://doi.org/10.1101/2021.11.15.21266341

Article usage

Article usage: November 2021 to November 2024

AbstractFullPdf
Nov 2021152594373561
Dec 2021114484921904
Jan 202251021701588
Feb 2022215848382
Mar 2022159639295
Apr 2022101950180
May 202271241158
Jun 202249016106
Jul 20224441995
Aug 2022407685
Sep 20224792168
Oct 20224553689
Nov 20223001563
Dec 2022328664
Jan 20232401584
Feb 20232001162
Mar 2023207460
Apr 2023150666
May 2023134751
Jun 2023146641
Jul 2023128551
Aug 20232151154
Sep 20234457177
Oct 2023377383
Nov 20232391345
Dec 2023112444
Jan 20241455108
Feb 2024855122
Mar 202497258
Apr 2024110959
May 2024112250
Jun 20241091140
Jul 20241001055
Aug 202494747
Sep 202498748
Oct 2024861349
Nov 202456236
Back to top
Posted November 15, 2021.
Download PDF
Data/Code
Email
Effectiveness of BNT162b2 (Comirnaty, Pfizer-BioNTech) COVID-19 booster vaccine against covid-19 related symptoms in England: test negative case-control study
Nick Andrews, Julia Stowe, Freja Kirsebom, Charlotte Gower, Mary Ramsay, Jamie Lopez Bernal
medRxiv 2021.11.15.21266341; doi: https://doi.org/10.1101/2021.11.15.21266341
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area